MedPAC > Our Work > Effects of pharmaceutical manufacturer rebates on Part D’s risk adjustment Effects of pharmaceutical manufacturer rebates on Part D’s risk adjustment Oct 30, 2020 / Meeting Brief Download Full Meeting Brief